| Literature DB >> 35470599 |
Abstract
BACKGROUND: Human immunodeficiency virus (HIV) disclosure provides personal support to people living with HIV/acquired immunodeficiency syndrome (PLWH). In addition, it has important implications for disease prevention and treatment. Research on disclosure has been conducted worldwide; however, data from South Korea are insufficient. The purpose of this study was to examine whether certain demographic, medical, and psychosocial factors act as predictors of HIV serostatus non-disclosure among PLWH in South Korea.Entities:
Keywords: Anxiety; Depression; Disclosure; HIV; Stigma
Mesh:
Year: 2022 PMID: 35470599 PMCID: PMC9039200 DOI: 10.3346/jkms.2022.37.e125
Source DB: PubMed Journal: J Korean Med Sci ISSN: 1011-8934 Impact factor: 2.153
Demographic, clinical data and psychiatric measures of the study sample (N = 147)
| Variables | Values | |
|---|---|---|
| Age, yr | 42.7 ± 12.5 | |
| Sex | ||
| Male | 142 (96.6) | |
| Female | 5 (3.4) | |
| Marital status | ||
| Single | 100 (68.0) | |
| Married | 29 (19.7) | |
| Separated/Divorced/Widowed | 17 (11.6) | |
| Employment | ||
| Yes | 96 (65.3) | |
| No | 49 (33.3) | |
| Monthly income | ||
| ≤ 3 million won | 98 (66.7) | |
| > 3 million won | 42 (28.6) | |
| Education | ||
| ≤ High school | 74 (50.3) | |
| > High school | 72 (49.0) | |
| Religion | ||
| Yes | 50 (34.0) | |
| No | 96 (65.3) | |
| HIV transmission route | ||
| Homosexual/bisexual | 67 (45.6) | |
| Heterosexual | 22 (15.0) | |
| Injection/blood | 1 (.7.0) | |
| Don’t know | 55 (37.4) | |
| Experience with AIDS related diseases | ||
| Yes | 46 (31.3) | |
| No | 101 (68.7) | |
| ART adherence | ||
| Very good | 132 (89.8) | |
| Not very good | 15 (10.2) | |
| Disclosure | ||
| Disclosed | 90 (61.2) | |
| Non-disclosed | 57 (38.8) | |
| ART period from start, mon | 71.3 ± 58.6 | |
| CD4 T-cell count, cells/µL | 610.3 ± 428.7 | |
| HIV quantitative RT-PCR, copies/mL | 8,544.9 ± 87,642.9 | |
| PHQ-9 | 5.9 ± 6.3 | |
| GAD-7 | 4.4 ± 4.8 | |
| HSS-R | ||
| Disclosure concerns | 25.2 ± 5.1 | |
| Negative self-image | 17.8 ± 4.9 | |
| Concerns with public attitudes | 19.0 ± 4.2 | |
| Enacted stigma (Disclosed group, n = 90) | 23.2 ± 8.5 | |
Values are expressed as mean ± standard deviation or number (%).
HIV = human immunodeficiency virus, AIDS = acquired immunodeficiency syndrome, ART = antiretroviral therapy, RT-PCR = reverse transcription polymerase chain reaction, PHQ-9 = Patient Health Questionnaire-9, GAD-7 = Generalized Anxiety Disorder-7, HSS-R = revised HIV Stigma Scale.
Results of χ2 test comparing the medical and psychosocial factors between disclosed and non-disclosed group
| Variables | Disclosed | Non-disclosed | χ2 |
| |
|---|---|---|---|---|---|
| Marital status | 15.249 | < 0.001*** | |||
| Single | 66 (66.0) | 34 (34.0) | |||
| Married | 9 (31.0) | 20 (69.0) | |||
| Divorced/separated/widowed | 14 (82.4) | 3 (17.6) | |||
| Total | 89 (61.0) | 57 (39.0) | |||
| Employment | 0.661 | 0.416 | |||
| Employed | 56 (58.3) | 40 (41.7) | |||
| Unemployed | 32 (65.3) | 17 (34.7) | |||
| Total | 88 (60.7) | 57 (39.3) | |||
| Monthly income | 0.036 | 0.850 | |||
| Low | 59 (60.2) | 39 (39.8) | |||
| High | 26 (61.9) | 16 (38.1) | |||
| Total | 85 (60.7) | 55 (39.3) | |||
| Education | 3.995 | 0.046* | |||
| Low | 51 (68.9) | 23 (31.1) | |||
| High | 38 (52.8) | 34 (47.2) | |||
| Total | 89 (61.0) | 57 (39.0) | |||
| Religion | 0.280 | 0.597 | |||
| Yes | 29 (58.0) | 21 (42.0) | |||
| No | 60 (62.5) | 36 (37.5) | |||
| Total | 89 (61.0) | 57 (39.0) | |||
| Experience with AIDS related diseases | 1.072 | 0.300 | |||
| Yes | 31 (67.4) | 15 (32.6) | |||
| No | 59 (58.4) | 42 (41.6) | |||
| Total | 90 (61.2) | 57 (38.8) | |||
| ART adherence | 0.208 | 0.648 | |||
| Very good | 80 (60.6) | 52 (39.4) | |||
| Not very good | 10 (66.7) | 5 (33.3) | |||
| Total | 90 (61.2) | 57 (38.8) | |||
Values are expressed as number (%).
AIDS = acquired immunodeficiency syndrome, ART = antiretroviral therapy.
*P < 0.05, ***P < 0.001.
Results of independent two sample t-test comparing the medical and psychosocial factors between disclosed and non-disclosed group
| Variables | Disclosed | Non-disclosed | t |
|
|---|---|---|---|---|
| No. of patients | 90 (61.2) | 57 (38.8) | ||
| Age | 40.99 ± 12.16 | 45.44 ± 12.67 | −2.128 | 0.035* |
| ART period from start, mon | 75.94 ± 63.49 | 64.05 ± 49.45 | 1.202 | 0.231 |
| CD4 T-cell count, cells/µL | 602.15 ± 287.83 | 623.05 ± 589.21 | −0.287 | 0.774 |
| HIV quantitative RT-PCR. copies/mL | 2,216.17 ± 18,121.18 | 18,537.65 ± 139,062.16 | −1.101 | 0.273 |
| Depression (PHQ-9) | 6.83 ± 6.58 | 4.39 ±5.44 | 2.448 | 0.016* |
| Anxiety (GAD-7) | 4.96 ± 5.14 | 3.53 ± 4.20 | 1.759 | 0.081 |
| Disclosure concerns | 24.18 ± 5.14 | 26.73 ± 4.68 | −3.030 | 0.003** |
| Negative self-image | 17.85 ± 5.13 | 17.82 ± 4.41 | 0.037 | 0.971 |
| Concerns with public attitudes | 18.58 ± 4.42 | 19.55 ± 3.81 | −1.376 | 0.171 |
Values are expressed as mean ± standard deviation or number (%).
ART = antiretroviral therapy, HIV = human immunodeficiency virus, RT-PCR = reverse transcription polymerase chain reaction, PHQ-9 = Patient Health Questionnaire-9, GAD-7 = Generalized Anxiety Disorder-7.
*P < 0.05, **P < 0.01.
Results of Pearson correlation test for continuous variable
| Variables | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1. Enacted stigmaa | 1 | |||||||||
| 2, Depression | 0.447** | 1 | ||||||||
| 3. Anxiety | 0.415** | 0.850** | 1 | |||||||
| 4. Disclosure concerns | 0.492** | 0.169* | 0.182* | 1 | ||||||
| 5. Negative self-image | 0.421** | 0.281** | 0.299** | 0.479** | 1 | |||||
| 6. Concerns with public attitudes | 0.418** | 0.310** | 0.317** | 0.646** | 0.541** | 1 | ||||
| 7. Age | 0.281** | −0.011 | −0.053 | 0.031 | 0.023 | 0.016 | 1 | |||
| 8. ART duration | 0.178 | 0.240** | 0.173* | −0.116 | −0.046 | −0.028 | 0.366** | 1 | ||
| 9. CD4+ T cell | −0.095 | −0.071 | −0.104 | −0.046 | −0.003 | −0.028 | −0.051 | 0.057 | 1 | |
| 10. HIV PCR quantitative | 0.186 | 0.018 | 0.066 | −0.057 | −0.085 | −0.142 | −0.014 | 0.068 | −0.031 | 1 |
ART = antiretroviral therapy, HIV = human immunodeficiency virus, PCR = polymerase chain reaction.
aEnacted stigma (n = 90) measured only in disclosed group.
*P < 0.05, **P < 0.01, ***P < 0.001.
Results of Logistic regression analysis for factors predicting HIV status non-disclosure
| Predictors | B | SE | OR | 95%CI |
| |
|---|---|---|---|---|---|---|
| HIV serostatus non-disclosure | ||||||
| Depression | −0.086 | 0.037 | 0.918 | (0.853–0.987) | 0.021* | |
| Disclosure concerns | 0.125 | 0.043 | 1.133 | (1.040–1.234) | 0.004** | |
| Marriage_Single (ref) | 0.011* | |||||
| Marriage_Married | 1.099 | 0.485 | 3.002 | (1.160–7.772) | 0.024* | |
| Marriage_Separated/Divorced/Widowed | −1.102 | 0.711 | 0.332 | (0.083–1.339) | 0.121 | |
| −2LL = 161.300; Nagelkerke R2 = 0.232; Hosmer & Lemeshow test: χ2=13.189 ( | ||||||
HIV = human immunodeficiency virus, SE = standard error, OR = odds ratio, CI = confidence interval.
*P < 0.05, **P < 0.01.
Results of Fisher’s exact test comparing the medical and psychosocial factors between disclosed and non-disclosed group
| Variables | Disclosed | Non-disclosed | Fisher's exact test ( | |
|---|---|---|---|---|
| Sex | 1.000 | |||
| Male | 87 (61.3) | 55 (38.7) | ||
| Female | 3 (60.0) | 2 (40.0) | ||
| Total | 90 (61.2) | 57 (38.8) | ||
| HIV transmission route (%) | 0.805 | |||
| Homosexual/bisexual | 43 (64.2) | 24 (35.8) | ||
| Heterosexual | 13 (59.1) | 9 (40.9) | ||
| Injection/blood | 1 (100.0) | 0 (0.0) | ||
| Don’t know | 31 (56.4) | 24 (43.6) | ||
| Total | 88 (60.7) | 57 (39.3) | ||
Values are expressed as number (%).
HIV = human immunodeficiency virus.